Cosciens Biopharma Inc
(CSCIF)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2013 | 12-2012 | 09-2012 | 06-2012 | 03-2012 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 1,880 | -20,410 | N/A | -6,910 | -11,450 |
| Depreciation Amortization | 260 | 1,190 | N/A | 570 | 1,600 |
| Other Working Capital | -340 | -7,590 | N/A | -2,110 | -2,350 |
| Other Operating Activity | -7,650 | -4,000 | 0 | -6,460 | 3,810 |
| Operating Cash Flow | $-5,850 | $-30,810 | $N/A | $-14,910 | $-8,390 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -20 | -270 | N/A | -100 | -40 |
| Investing Cash Flow | $-20 | $-270 | $N/A | $-100 | $-40 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | -30 | 24,200 | 0 | 8,660 | 6,810 |
| Financing Cash Flow | $-30 | $24,200 | $N/A | $8,660 | $6,810 |
| Exchange Rate Effect | -430 | -480 | N/A | -760 | 320 |
| Beginning Cash Position | 39,520 | 46,880 | N/A | 46,880 | 46,880 |
| End Cash Position | 33,180 | 39,520 | N/A | 39,750 | 45,580 |
| Net Cash Flow | $-6,330 | $-7,360 | $N/A | $-7,120 | $-1,290 |
| Free Cash Flow | |||||
| Operating Cash Flow | -5,850 | -30,810 | N/A | -14,910 | -8,390 |
| Free Cash Flow | -5,850 | -30,810 | 0 | -14,910 | -8,390 |